Yokohama, Japan

Shigeki Masui

This inventor holds 1 USPTO granted patent. Top assignee: Pola Chemical Industries, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeki Masui. Retrieved from https://idiyas.com/inventor/shigeki-masui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shigeki Masui: Innovator in Monoclonal Antibody Development

Introduction

Shigeki Masui is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Shigeki Masui holds a patent for an anti-human tyrosinase monoclonal antibody. This invention is crucial for advancing treatments related to skin conditions and other medical issues associated with tyrosinase.

Career Highlights

Masui is currently employed at Pola Chemical Industries, Inc., where he continues to engage in groundbreaking research and development. His expertise in monoclonal antibodies positions him as a key player in the biotechnology sector.

Collaborations

He has collaborated with notable colleagues, including Hiroyuki Takimoto and Satoshi Suzuki. These partnerships enhance the innovative capacity of their projects and contribute to the advancement of their research.

Conclusion

Shigeki Masui's contributions to the field of biotechnology, particularly through his patent for an anti-human tyrosinase monoclonal antibody, highlight his role as an influential inventor. His work at Pola Chemical Industries, Inc. and collaborations with esteemed colleagues further underscore his impact on medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…